Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Dan

Showing results (61-70 of 64) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 64 results.
Magnetic Resonance Imaging|January 1, 2017
Intravoxel incoherent motion and diffusion tensor imaging of early renal fibrosis induced in a murine model of streptozotocin induced diabetesY Y Yan, S Hartono, T Hennedige, et al.
Alimentary Pharmacology & Therapeutics|January 16, 2018
Clinical features and treatment of nonalcoholic fatty liver disease across the Asia Pacific region-the GO ASIA initiativeW-K Chan, S Treeprasertsuk, K Imajo, et al.
Alimentary Pharmacology & Therapeutics|February 26, 2013
Resolution of adefovir-related nephrotoxicity by adefovir dose-reduction in patients with chronic hepatitis BJ L Hartono, M O Aung, Y Y Dan, et al.
Hepatology International|May 13, 2026
The Asian Pacific Association of the Study of the Liver expert survey on artificial intelligence-assisted reporting of liver histopathology in metabolic dysfunction associated fatty liver diseaseH Elangovan, K Akbary, A Rastogi, et al.
Pageof 7

Showing results (61-70 of 64) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 64 results.
Magnetic Resonance Imaging|January 1, 2017
Intravoxel incoherent motion and diffusion tensor imaging of early renal fibrosis induced in a murine model of streptozotocin induced diabetesY Y Yan, S Hartono, T Hennedige, et al.
Alimentary Pharmacology & Therapeutics|January 16, 2018
Clinical features and treatment of nonalcoholic fatty liver disease across the Asia Pacific region-the GO ASIA initiativeW-K Chan, S Treeprasertsuk, K Imajo, et al.
Alimentary Pharmacology & Therapeutics|February 26, 2013
Resolution of adefovir-related nephrotoxicity by adefovir dose-reduction in patients with chronic hepatitis BJ L Hartono, M O Aung, Y Y Dan, et al.
Hepatology International|May 13, 2026
The Asian Pacific Association of the Study of the Liver expert survey on artificial intelligence-assisted reporting of liver histopathology in metabolic dysfunction associated fatty liver diseaseH Elangovan, K Akbary, A Rastogi, et al.
Pageof 7